Organon (OGN) Return on Equity [ROE] (2020 - 2026)
Organon (OGN) recorded Return on Equity [ROE] of 21.90% in Q2 2026, down 87.91 percentage points from 109.80% a year earlier and down 7.83 percentage points from the prior quarter.
Powered by 
Analysis
Organon (OGN) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2025, Organon reported Return on Equity [ROE] of 30.56%, down 399.30 percentage points from FY2024.
- Annual Return on Equity [ROE] has a five-year change of -3.95 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at 429.85% in FY2024 and 67.92% in FY2021 (+33.42 pp).
- The Q2 2026 figure is the lowest quarterly Return on Equity [ROE] in data going back to Q4 2020.
- On a year-over-year basis, Return on Equity [ROE] has declined for five consecutive quarters, with an average year-over-year change of -328.36 percentage points over the last five quarters.
- Per Business Quant, the preceding three quarters came in at 29.73% (Q1 2026), 22.56% (Q4 2025) and 61.13% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | - |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 4.97% |
| 10 | Organon | 3.61 Bn | 118.21 Mn | 847.00 Mn | 21.90% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.90% |
| Mar 31, 2026 | 29.73% |
| Dec 31, 2025 | 22.56% |
| Sep 30, 2025 | 61.13% |
| Jun 30, 2025 | 109.80% |
| Mar 31, 2025 | 147.93% |
| Dec 31, 2024 | 179.07% |
| Sep 30, 2024 | 408.48% |
| Jun 30, 2024 | 1,041.67% |
| Jun 30, 2021 | 124.89% |
| Mar 31, 2021 | 36.36% |
| Dec 31, 2020 | 33.69% |
API Access
Organon Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "OGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();